These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9329068)

  • 1. Anxiolytic action of a neurokinin1 receptor antagonist in the social interaction test.
    File SE
    Pharmacol Biochem Behav; 1997 Nov; 58(3):747-52. PubMed ID: 9329068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NKP608, an NK1 receptor antagonist, has an anxiolytic action in the social interaction test in rats.
    File SE
    Psychopharmacology (Berl); 2000 Sep; 152(1):105-9. PubMed ID: 11041322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiolytic effect of NKP608, a NK1-receptor antagonist, in the social investigation test in gerbils.
    Gentsch C; Cutler M; Vassout A; Veenstra S; Brugger F
    Behav Brain Res; 2002 Jul; 133(2):363-8. PubMed ID: 12110470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiolytic actions of the substance P (NK1) receptor antagonist L-760735 and the 5-HT1A agonist 8-OH-DPAT in the social interaction test in gerbils.
    Cheeta S; Tucci S; Sandhu J; Williams AR; Rupniak NM; File SE
    Brain Res; 2001 Oct; 915(2):170-5. PubMed ID: 11595206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NKP608: a selective NK-1 receptor antagonist with anxiolytic-like effects in the social interaction and social exploration test in rats.
    Vassout A; Veenstra S; Hauser K; Ofner S; Brugger F; Schilling W; Gentsch C
    Regul Pept; 2000 Dec; 96(1-2):7-16. PubMed ID: 11102646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dorsal raphé nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses.
    Cheeta S; Irvine EE; Kenny PJ; File SE
    Psychopharmacology (Berl); 2001 Apr; 155(1):78-85. PubMed ID: 11374339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of treatment regimen on the development of tolerance to the sedative and anxiolytic effects of diazepam.
    Fernandes C; Arnot MI; Irvine EE; Bateson AN; Martin IL; File SE
    Psychopharmacology (Berl); 1999 Aug; 145(3):251-9. PubMed ID: 10494573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists.
    Varty GB; Cohen-Williams ME; Morgan CA; Pylak U; Duffy RA; Lachowicz JE; Carey GJ; Coffin VL
    Neuropsychopharmacology; 2002 Sep; 27(3):371-9. PubMed ID: 12225694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.
    Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC
    Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropharmacology of a new potential anxiolytic compound, F 2692, 1-(3'-trifluoromethyl phenyl) 1, 4-dihydro 3-amino 4-oxo 6-methyl pyridazine. 2. Evaluation of its tolerance and dependence producing potential and of its effects on benzodiazepine withdrawal in the elevated plus-maze test in rats.
    Chopin P; Assié MB; Briley M
    Psychopharmacology (Berl); 1993; 110(1-2):19-26. PubMed ID: 7870883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinolines and anxiety: anxiogenic effects of CGS 8216 and partial anxiolytic profile of PK 9084.
    File SE; Lister RG
    Pharmacol Biochem Behav; 1983 Feb; 18(2):185-8. PubMed ID: 6132404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diazepam and nicotine increase social interaction in gerbils: a test for anxiolytic action.
    File SE; Cheeta S; Akanezi C
    Brain Res; 2001 Jan; 888(2):311-313. PubMed ID: 11150490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diazepam withdrawal responses measured in the social interaction test of anxiety and their reversal by baclofen.
    File SE; Mabbutt PS; Andrews N
    Psychopharmacology (Berl); 1991; 104(1):62-6. PubMed ID: 1882005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NK1 receptor antagonist NKP608 lacks anxiolytic-like activity in Swiss-Webster mice exposed to the elevated plus-maze.
    Rodgers RJ; Gentsch C; Hoyer D; Bryant E; Green AJ; Kolokotroni KZ; Martin JL
    Behav Brain Res; 2004 Sep; 154(1):183-92. PubMed ID: 15302124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral effects of saredutant, a tachykinin NK2 receptor antagonist, in experimental models of mood disorders under basal and stress-related conditions.
    Micale V; Tamburella A; Leggio GM; Mazzola C; Li Volsi V; Drago F
    Pharmacol Biochem Behav; 2008 Sep; 90(3):463-9. PubMed ID: 18495229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-course of changes in the social interaction test of anxiety following acute and chronic administration of nicotine.
    Irvine EE; Cheeta S; File SE
    Behav Pharmacol; 1999 Nov; 10(6-7):691-7. PubMed ID: 10780511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiolytic profile of HG1, a 5-HT-moduline antagonist, in three mouse models of anxiety.
    Clénet F; Hascoët M; Fillion G; Galons H; Bourin M
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):449-56. PubMed ID: 15589384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of shock-induced foot tapping behaviour in the gerbil by a tachykinin NK1 receptor antagonist.
    Ballard TM; Sänger S; Higgins GA
    Eur J Pharmacol; 2001 Feb; 412(3):255-64. PubMed ID: 11166289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective blockade of NK2 or NK3 receptors produces anxiolytic- and antidepressant-like effects in gerbils.
    Salomé N; Stemmelin J; Cohen C; Griebel G
    Pharmacol Biochem Behav; 2006 Apr; 83(4):533-9. PubMed ID: 16624395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism.
    Nakamura K; Kurasawa M
    Eur J Pharmacol; 2001 May; 420(1):33-43. PubMed ID: 11412837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.